WE CREATE - SPARK THERA-PEUTI MEDI-SparkMedical.com
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
SPARK
THERA-
PEUTI
MEDI- CAL
AFFAIRS FELLOWSHIP
MEDICAL AFFAIRS FELLOWSHIP
WE CREATE
2022—2024
SPARK THERAPEUTICS
Our Mission
Challenge the inevitability of genetic disease by
discovering, developing and delivering treatments
in ways unimaginable – until now.
Our Vision
A world where no life is limited by genetic disease.
Jeff Marrazzo, MBA
CEO, Co-Founder
“Spark Therapeutics was founded on the idea that gene
therapy has the potential to spark great change in the lives of
people affected by rare genetic diseases. At Spark,
exploration is the backbone of possibility and we bring that
passion for innovation to everything we do. We are focused
on discovering, developing, and delivering gene therapies to
people living with genetic diseases in the United States and
around the world.”
WE ARE SPARK
At Spark Therapeutics, a fully integrated, commercial company committed to discovering, developing and
delivering gene therapies, we challenge the inevitability of genetic diseases, including blindness, hemophilia,
lysosomal storage disorders, hereditary angioedema, and neurodegenerative diseases.
Founded in March 2013 as a result of the technology and know-how accumulated over two decades at Children’s
Hospital of Philadelphia (CHOP), our investigational therapies have the potential to provide long-lasting effects,
dramatically and positively changing the lives of patients with conditions where no, or only palliative, therapies
exist. Greater understanding of the human genome and genetic abnormalities have allowed our scientists to
tailor investigational therapies to patients suffering from very specific genetic diseases. This approach holds great
promise in developing effective treatments to a host of inherited diseases. Our initial focus is on treating orphan
diseases.
Headquartered in dynamic Philadelphia, we are a diverse, experienced team united in our goal to break down
barriers for people and families affected by genetic diseases. As our name suggests, our investigational, one-time
therapies are designed to spark healthy biology and deliver potentially life-altering transformation for people and
families affected by genetic disease. Spark is a member of the Roche Group.
Our Scientific Platform and Programs
Spark Therapeutics has built a leading integrated gene therapy platform as we strive to turn genes into medicines
for patients with inherited diseases, including inherited retinal diseases (IRDs), liver-directed diseases such as
hemophilia and lysosomal storage disorders, hereditary angioedema, and neurodegenerative diseases.
MEDICAL AFFAIRS LEADERSHIP
At Spark Therapeutics, our Medical Affairs department seeks to actively engage with physicians, researchers, and
other healthcare professionals around the world to provide education about the field of gene therapy and
respond to inquiries about our approved and investigational gene therapies and related genetic diseases. As a
team of healthcare professionals, we are continually inspired by the patients we serve. Through collaboration and
passion for what we do every day, we strive to address and bring focus to unmet needs in rare genetic diseases.
Our Medical Affairs team looks forward to welcoming you as you embark on your journey of professional growth!
Bartholomew J Tortella, MTS, MD
MBA, FACS, FCCM
Head of Medical Affairs
FELLOWSHIP LEADERSHIP
Olga Esterzon, PharmD
Medical Information Leader
“As a former fellow, I know how a fellowship program can shape your future career in the
pharmaceutical industry. Our Spark Therapeutics Pharm.D. Fellowship has been thoughtfully
designed to allow you to grow professionally and gain valuable experience in areas that match
your individual interests, while contributing to the company’s overall goals. I strongly
encourage you to take the next steps by pursuing a fellowship as an investment in your future
career and professional success.”
Dan Manning, PharmD
Head of Field Medical Teams
“The gene therapy pharmacy fellowship will provide a rare opportunity for a candidate to learn
and work in a cutting-edge company. Spark and its gene therapy research is pioneering the
new wave of innovation in potential treatments for the future. The fellowship program will give
a candidate a chance to learn and be a part of a growing gene therapy field.”
CURRENT FELLOWS
Veslyne Vincent, PharmD
Spark 2020-2022 Fellow-Contractor
“Starting my journey as a fellow, I have quickly become an integral part of a team with
mentors that are fully invested in my career development. The cross-functional nature of
the fellowship provides me with opportunities to work in a wide array of therapeutic areas
while developing my technical and soft skills. The knowledge and skillset I am gaining
during my time at Spark, will allow me to smoothly transition to a career in the
pharmaceutical industry.”
Rebecca James, PharmD, MPH
Spark 2021-2023 Fellow-Contractor
“I have been welcomed into Spark’s cross-functional team-oriented environment which is
focused on ensuring I can explore every aspect of Medical Affairs and other industry
functions. It is a privilege to work on gene therapy projects and make an impact on the lives
of patients with rare diseases in addition to the future of medicine. The leadership growth
and development of transferable skills produced from this fellowship will allow me to launch
a successful career in the pharmaceutical industry.”
FELLOWSHIP ALUMNI
Joy Onuma, PharmD
Fellow 2018-2019
Medical Science Liaison—Spark Therapeutics
“Spark's fellowship program allowed me to gain a robust knowledge of the biopharmaceuti-
cal industry and hands-on experience within Medical Affairs. Most importantly, it provided a
solid foundation in both training and relationships that I continue to leverage in my current
role as an Medical Science Liaison.”
Rajvi Shah, PharmD
Fellow 2019-2020
Medical Science Liaison—Spark Therapeutics
“As a fellow at Spark Therapeutics, I was always encouraged and supported to take every
opportunity to learn and lead on a diverse range of projects within Medical Affairs. With the
nature of this unique rotational fellowship and under the incredible mentorship of accomplished
professionals, the Spark fellowship has truly given me the tools I needed to secure myself into
the career of my choice.”
PROGRAM OVERVIEW
Recruiting
1 fellow
Description
This unique 2-year Medical Affairs fellowship program in a biotechnology company provides the
fellow an opportunity to gain hands-on experience contributing to the various functional areas
within Medical Affairs. By serving as an integral member of the Medical Affairs team, the fellow
will gain a deep understanding of the science behind gene therapy as it applies to Spark
Therapeutics' areas of focus, as well as the interplay between different functions within a
biotechnology company.
The program includes three mandatory rotations: Medical Information, Medical Communications,
Medical Science Liaison, and one elective rotation most aligned with the fellow’s interest and
company need. Each of the four rotations is six months in duration. Potential opportunities to
assist other internal stakeholders with projects will be determined on a case-to-case basis, but are
highly encouraged.
MEDICAL AFFAIRS FELLOWSHIP: ROTATIONS
• Understand the role and responsibilities of a Medical Information Specialist in the bio-
technology industry
• Create and provide timely, accurate, and balanced medical/scientific and technical
information in response to inquiries from healthcare professionals, consumers, and
managed care organizations with materials such as standard and customized response
documents, scientific slide decks, and clinical dossiers
• Provide high quality review of promotional, commercial, medical, and scientific materials
to ensure accuracy and balance of medical and scientific content
Denise Pauzano, PharmD
• Attend medical and scientific meetings and congresses to provide support for Medical Medical Information Lead
Information and/or medical education booths Preceptor
• Attend internal Medical Affairs meetings and collaborate with other key stakeholders
outside of Medical Information
• Understand the role and skills required of a Medical Communications Professional as
a specialized Medical Affairs function in the biotechnology industry
• Collaborate with Medical Affairs team members and cross–functional partners to
develop a plan that supports strategic and tactical communication of scientific data
• Develop a thorough understanding of the core principles of Good Publications
Practices (GPP3) for industry-based publications and work through the development
of a publication, starting with concept development to submission to a publications
platform (scientific journal or congress)
• Learn how to develop a team-based comprehensive congress plan that incorporates
Christine O’Leary, PharmD, BCPS
strategic objectives and the derivative tactics Medical Communications Lead
• Learn the principles of project management and prioritization in the context of Preceptor
medical communication
• Learn and apply the core functions of the Medical Science Liaison (MSL) role by
effectively delivering clinical presentations to internal and external stakeholders,
developing peer-to-peer relationships with key opinion leaders (KOLs), and
optimizing communication of key insights from the field back to the team
• Play a critical role in field medical operations, assisting in the development of
insight reports, territory plans and optimizing field medical use of customer
management tools
• Collaborate with Medical Directors, Medical Communications and vendors in the
creation and revision of field medical resources and training materials Ruth Haile-Meskale, PharmD, MBA
• Participate in the congress planning process from identification of relevant Medical Science Liaison Lead
Preceptor
content to coverage of sessions at the conference and development of a
summary of key learnings
Elective Rotation
Elective rotations are contingent upon preceptor availability at the time of elective rotation selection. The extension of
one of the Medical Affairs functional roles may also be an alternative elective opportunity and will be based mainly on
company need and/or candidate’s preference.
Opportunities for elective rotations may include functional areas such as:
• Regulatory Strategy
• Commercial Regulatory
• Clinical Development
• Pharmacovigilance
APPLICATION PROCESS
Thank you for your interest in the Spark Therapeutics Medical Affairs Fellowship Program.
Spark Therapeutics will conduct interviews independent of the ASHP Midyear Meeting.
Interested applicants should submit a curriculum vitae (CV) at https://careers.sparktx.com/
job/Philadelphia-Medical-Affairs-Fellowship-PA-19019/787495600/. Deadline for application
submissions is October 29, 2021.
REQUIREMENTS
• Candidates must have:
• A Doctor of Pharmacy degree from an Accreditation Council for Pharmacy
Education (ACPE) accredited school or college prior to their start date
• Ability to legally work in the United States for the duration of the
program
• Candidates who are selected for 3rd round interviews will need to provide:
• An official pharmacy school transcript
• Two formal letters of recommendation sent to:
MedicalAffairsFellowship@SparkTX.com
TIMELINE
• First round interviews will take place from November 8-12, 2021.
• If selected, second round interviews will take place from November 15-18, 2021.
• Invitations for final round interviews will be extended to select candidates by
November 19, to take place from November 30-December 2, 2021.
• Final selection of the fellowship candidate will be made by December 6, 2021.
• The selected candidate will begin the fellowship program on July 6, 2022.
*All interviews will be conducted virtually
PREFERRED SKILLS
• Strong presentation and communication skills
• Scientific writing and literature evaluation skills
CONTACT INFORMATION
• Email: MedicalAffairsFellowship@SparkTX.com
**Please be aware that Spark mandates COVID-19 vaccination of all employees and contract workers
regardless of work location. Accommodations may be made by Spark in accordance with applicable law.
Spark Therapeutics does not discriminate on the basis of race, color, gender, identity, sexual orientation, age,
religion, national or ethnic origin, disability, protected veteran status or any other basis protected by applicable law.
Spark, Spark Therapeutics and its design are trademarks of Spark Therapeutics in the United States: © 2021 Spark Therapeutics, Inc. N-SPK-ALL-660001-2 All rights reserved.
You can also read
